Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1

Journal of Child Neurology

Volumn 17, Issue 8, 2002, Pages 622-626

  Costa, Rui M ^a   Silva, Alcino J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADENYLATE CYCLASE; GUANOSINE TRIPHOSPHATASE; NEUROFIBROMIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOCHEMISTRY; BRAIN FUNCTION; CELL DIFFERENTIATION; CELL GROWTH; COGNITIVE DEFECT; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE MUTATION; GENETIC DISORDER; HUMAN; LEARNING DISORDER; LONG TERM POTENTIATION; MICROTUBULE; MOUSE; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

EID: 0036700964     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700813     Document Type: Review

References (73)

1. Gutmann DH, Collins FS: von Recklinghausen neurofibromatosis, in Scriver CR, et al: The Metabolic and Molecular Basis of Inherited Disease, 7th ed, vol 2. New York, McGraw-Hill, 1995, 14:1-19.
2. Huson SM, Hughes RAC: The Neurofibromatoses: A Pathogenic and Clinical Overview. London, Chapman & Hall, 1994,
3. Viskochil D: Neurofibromatosis 1. Am J Med Genet 1999;89:v-viii.
4. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999;89:1-6.
5. Cichowski K, Jacks T: NF1 tumor suppressor gene function: Narrowing the GAP. Cell 2001;104:593-604.
6. North K: Neurofibromatosis type 1. Am J Med Genet 2000;97:119-127.
7. Ozonoff S: Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999;89:45-52.
8. Eliason MJ: Neurofibromatosis: Implications for learning and behavior. Dev Behav Pediatr 1986;7:175-179.
9. Eliason MJ: Neuropsychological patterns: Neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1988;1:17-25.
10. Varnhagen C, Lewin S, Das JP, et al: Neurofibromatosis and psychological processes. J Dev Behav Pediatr 1988;9:257-265.
11. Eldridge R, Denckla MB, Bien E, et al: Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls. Am J Dis Child 1989;143:833-837.
12. North K: Neurofibromatosis type 1: Review of the first 200 patients in an Australian clinic. J Child Neurol 1993;8:395-402.
13. North K, Joy P, Yuille D, et al: Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995;37:427-436.
14. Chapman CA, Waber DP, Bassett N, et al: Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific. Am J Med Genet 1996;67:127-132.
15. Zoller ME, Rembeck B, Backman L: Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurol Scand 1997;95:225-232.
16. North K, Joy P, Yuille D, et al: Specific learning disability in children with neurofibromatosis type I: Significance of MRI abnormalities. Neurology 1994;44:878-883.
17. Bernards A, Snijders AJ, Hannigan GE, et al: Mouse neurofibromatosis type 1 cDNA sequence reveals high degree of conservation of both coding and noncoding mRNA segments. Hum Mol Genet 1993;2:645-650.
18. Hajra A, Martin-Gallardo A, Tarle SA, et al: DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse. Genomics 1994;21:649-652.
19. Jacks T, Shih TS, Schmitt EM, et al: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 1994;7:353-361.
20. Brannan CI, Perkins AS, Vogel KS, et al: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-1029.
21. Cichowski K, Shih TS, Schmitt E, et al: Mouse models of tumor development in neurofibromatosis type 1. Science 1999;286:2172-2176.
22. Vogel KS, Klesse J, Velasco-Miguel S: Mouse tumor model for neurofibromatosis type 1. Science 1999;286:2176-2179.
23. Nordlund ML, Rizvi TA, Brannan CI, Ratner N: Neurofibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Exp Neurol 1995;54:588-600.
24. Rizvi TA, Akunuru S, de Courten-Myers G, et al: Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor. Brain Res 1999;816:111-123.
25. Silva AJ, Frankland PW, Marowitz Z, et al: A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet 1997;15:281-284.
26. Frankland PW, Cestari V, Filipkowski R, et al: The dorsal hippocampus is essential for context discrimination but not for contextual conditioning. Behav Neurosci 1998;112:863-874.
27. Easton D, Ponder M, Huson S, Ponder B: An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes. Am J Hum Genet 1993;53:305-313.
28. Costa RM, Elgersma Y, Silva AJ: Modeling cognitive disorders: From genes to therapies, in Fisch G (ed): Genetics and Genomics of Neurobehavioral Disorders. Totowa, NJ, Humana Press, 2002, in press.
29. Denckla MB, Hofman K, Mazzocco MM, et al: Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102.
30. Hofman KJ, Harris EL, Bryan RN, Denckla MB: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr 1994; 124(Suppl): S1-S8.
31. Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-378.
32. Ferner RE, Chaudhuri R, Bingham J, et al: MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56:492-495.
33. Legius E, Descheemaeker MJ, Steyaert J, et al: Neurofibromatosis type 1 in childhood: Correlation of MRI findings with intelligence. J Neurol Nèurosurg Psychiatry 1995;59:638-640.
34. Costa RM, Yang T, Huynh DP, et al: Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 2001;27:399-405.
35. Anderson LB, Pulst SM, Viscochil D: A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 1993; 13:487-495.
36. Viskochil DH: Gene structure and function in Upadhyaya M, Cooper DN (eds): Neurofibromatosis Type I: From Genotype to Phenotype. Oxford, BIOS Scientific Publishers Limited, 1998, 39-56.
37. Zhu Y, Romero MI, Ghosh P, et al: Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 2001;15:859-876.
38. Martin GA, Viskochil D, Bollag G, et al: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843-849.
39. Xu GF, Lin B, Tanaka K, et al: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990;63:835-841.
40. Ballester R, Marchuk D, Boguski M, et al: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990;63:851-859.
41. Guo HF, The I, Hannan F, et al: Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997;276:795-798.
42. Guo HF, Tong J, Hannan F, et al: A neurofibromatosis-1-regulated pathway is required for learning in Drosophila. Nature 2000; 403:895-898.
43. Xu H, Gutmann DH: Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res 1997;759:149-152.
44. Tong J, Hannan F, Zhu Y, et al: Neurofibromin regulates G protein-stimulated adenylyl cyclase activity. Nat Neurosci 2002;14:14.
45. Ingram DA, Hiatt K, King AJ, et al: Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001;194:57-69.
46. Williams JA, Su HS, Bernards A, et al: A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science 2001;293:2251-2256.
47. Klose A, Ahmadian MR, Schuelke M, et al: Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet 1998;7:1261-1268.
48. Costa RM, Federov NB, Kogan JH, et al: Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 2002;415:526-530.
49. Ohno M, Frankland PW, Chen AP, et al: Inducible, pharmacogenetic approaches to the study of learning and memory. Nat Neurosci 2001;4:1238-1243.
50. Brambilla R, Gnesutta N, Minichiello L, et al: A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 1997;390:281-286.
51. Atkins CM, Selcher JC, Petraitis J, et al: The MAPK cascade is required for mammalian associative learning. Nat Neurosci 1998; 1:602-609.
52. Giese KP, Friedman E, Telliez JB, et al: Hippocampus-dependent learning and memory is impaired in mice lacking the Ras-guanine-nucleotide releasing factor 1 (Ras-GRF1). Neuropharmacology 2001;41:791-800.
53. Minichiello L, Korte M, Wolfer D, et al: Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 1999;24:401-414.
54. Chen AP, Ohno M, Giese KP, et al: B-Raf kinase is critical for hippocampal ERK activation, long term potentiation and learning and memory. Submitted (2002).
55. Lin CH, Yeh SH, Lin CH, et al: A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 2001;31:841-851.
56. Abbott LF, Nelson SB: Synaptic plasticity: Taming the beast. Nat Neurosci 2000;3(Suppl):1178-1183.
57. Bliss TVP, Collingridge GL: A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993;361:31-39.
58. Malenka R, Nicoll RA: Long-term potentiation-A decade of progress? Science 1999;285:1870-1874.
59. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-683.
60. Cho YH, Friedman E, Silva AJ: Ibotenate lesions of the hippocampus impair spatial learning but not contextual fear conditioning in mice. Behav Brain Res 1999;98:77-87.
61. Scoville WB, Milner B: Loss of recent memory after hippocampal bilateral lesions. J Neurol Neurosurg Psychiatry 1957;20:11-12.
62. Zola-Morgan S, Squire LR: Neuroanatomy of memory Annu Rev Neurosci 1993;16:547-563.
63. Larson J, Wong D, Lynch G: Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation. Brain Res 1986;368:347-350.
64. Chorvatova A, Gendron L, Bilodeau L, et al: A Ras-dependent chloride current activated by adrenocorticotropin in rat adrenal zona glomerulosa cells. Endocrinology 2000;141:684-692.
65. Manabe T, Aiba A, Yamada A, et al: Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation. J Neurosci 2000;20:2504-2511.
66. Grant SG, O'Dell TJ: Multiprotein complex signaling and the plasticity problem. Curr Opin Neurobiol 2001;11:363-368.
67. Husi H, Ward MA, Choudhary JS, et al: Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci 2000;3:661-669.
68. Brioni JD, Decker MW, Gamboa LP, et al: Muscimol injections in the medial septum impair spatial learning. Brain Res 1990;522: 227-234.
69. Fujii S, Jia Y, Yang A, Sumikawa K: Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region. Brain Res 2000;863:259-265.
70. Lu YM, Mansuy IM, Kandel ER, Roder J: Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. Neuron 2000;26:197-205.
71. Gusev PA, Alkon DL: Intracellular correlates of spatial memory acquisition in hippocampal slices: Long-term disinhibition of CA1 pyramidal cells. J Neurophysiol 2001;86:881-899.
72. Paulsen O, Moser EI: A model of hippocampal memory encoding and retrieval: GABAergic control of synaptic plasticity. Trends Neurosci 1998;21:273-278.
73. Csicsvari J, Hirase H, Czurko A, et al: Oscillatory coupling of hippocampal pyramidal cells and interneurons in the behaving rat. J Neurosci 1999;19:274-287.